Covid-19: Health ministry decides not to put Itolizumab in national treatment protocol

Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab drug for restricted emergency use on moderate to severe Covid-19 patients, the Union health ministry has decided not to include the drug in the national treatment protocol for coronavirus patients. In the recent past, the National Task Force on Covid-19 constituted by the Health ministry held its meeting and discussed whether to put Itolizumab drug into the treatment protocol or not.